IMCD N.V [IMCD] vs DSM-Firmenich AG [DSFIR] Detailed Stock Comparison
IMCD N.V
Euronext
Loading...
DSM-Firmenich AG
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: IMCD N.V wins in 10 metrics, DSM-Firmenich AG wins in 9 metrics, with 0 ties. IMCD N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | IMCD N.V | DSM-Firmenich AG | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.20 | 30.13 | IMCD N.V |
| Price-to-Book Ratio | 2.90 | 1.01 | DSM-Firmenich AG |
| Debt-to-Equity Ratio | 87.66 | 25.24 | DSM-Firmenich AG |
| PEG Ratio | 14.33 | 27.04 | IMCD N.V |
| EV/EBITDA | 13.22 | 11.06 | DSM-Firmenich AG |
| Profit Margin (TTM) | 5.51% | 5.52% | DSM-Firmenich AG |
| Operating Margin (TTM) | 9.06% | 12.07% | DSM-Firmenich AG |
| EBITDA Margin (TTM) | 9.06% | 12.07% | DSM-Firmenich AG |
| Return on Equity | 14.31% | 3.52% | IMCD N.V |
| Return on Assets (TTM) | 6.01% | 2.18% | IMCD N.V |
| Free Cash Flow (TTM) | $252.76M | $1.01B | DSM-Firmenich AG |
| Dividend Yield | 1.91% | 2.63% | DSM-Firmenich AG |
| 1-Year Return | -30.42% | -31.35% | IMCD N.V |
| Price-to-Sales Ratio (TTM) | 1.18 | 1.64 | IMCD N.V |
| Enterprise Value | $7.22B | $24.47B | DSM-Firmenich AG |
| EV/Revenue Ratio | 1.49 | 1.88 | IMCD N.V |
| Revenue per Share (TTM) | $83 | $49 | IMCD N.V |
| Earnings per Share (Diluted) | $4.57 | $2.72 | IMCD N.V |
| Beta (Stock Volatility) | 1.00 | 1.04 | IMCD N.V |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
IMCD N.V vs DSM-Firmenich AG Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| IMCD N.V | -0.12% | 2.54% | -14.47% | -18.71% | -35.29% | -32.06% |
| DSM-Firmenich AG | -0.22% | 1.28% | -8.97% | -12.14% | -14.13% | -15.05% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| IMCD N.V | -30.42% | -36.58% | 8.13% | 195.69% | 332.63% | 332.63% |
| DSM-Firmenich AG | -31.35% | -31.26% | -31.26% | -31.26% | -31.26% | -31.26% |
Performance & Financial Health Analysis: IMCD N.V vs DSM-Firmenich AG
| Metric | IMCD | DSFIR |
|---|---|---|
| Market Information | ||
| Market Cap | €5.72B | €21.30B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 348,546 | 656,515 |
| 90 Day Avg. Volume | 211,700 | 507,777 |
| Last Close | €96.78 | €82.38 |
| 52 Week Range | €92.40 - €159.00 | €80.82 - €124.85 |
| % from 52W High | -39.13% | -34.02% |
| All-Time High | €211.30 (Dec 06, 2021) | €124.85 (Sep 30, 2024) |
| % from All-Time High | -54.20% | -34.02% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.03% |
| Quarterly Earnings Growth | -0.08% | 11.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.06% |
| Operating Margin (TTM) | 0.09% | 0.12% |
| Return on Equity (TTM) | 0.14% | 0.04% |
| Debt to Equity (MRQ) | 87.66 | 25.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €33.46 | €81.03 |
| Cash per Share (MRQ) | €3.23 | €10.85 |
| Operating Cash Flow (TTM) | €239.85M | €1.59B |
| Levered Free Cash Flow (TTM) | €229.19M | €921.50M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.91% | 2.63% |
| Last 12-Month Dividend | €2.15 | €2.50 |
Valuation & Enterprise Metrics Analysis: IMCD N.V vs DSM-Firmenich AG
| Metric | IMCD | DSFIR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.20 | 30.13 |
| Forward P/E | 14.33 | 27.04 |
| PEG Ratio | 14.33 | 27.04 |
| Price to Sales (TTM) | 1.18 | 1.64 |
| Price to Book (MRQ) | 2.90 | 1.01 |
| Market Capitalization | ||
| Market Capitalization | €5.72B | €21.30B |
| Enterprise Value | €7.22B | €24.47B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.49 | 1.88 |
| Enterprise to EBITDA | 13.22 | 11.06 |
| Risk & Other Metrics | ||
| Beta | 1.00 | 1.04 |
| Book Value per Share (MRQ) | €33.46 | €81.03 |
Financial Statements Comparison: IMCD N.V vs DSM-Firmenich AG
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IMCD | DSFIR |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IMCD | DSFIR |
|---|---|---|
| Cash & Equivalents | €522.78M | €2.67B |
| Total Current Assets | €2.07B | €8.80B |
| Total Current Liabilities | €1.05B | €4.36B |
| Long-Term Debt | €1.40B | €4.44B |
| Total Shareholders Equity | €2.22B | €22.70B |
| Retained Earnings | €912.74M | N/A |
| Property, Plant & Equipment | €20.29M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IMCD | DSFIR |
|---|---|---|
| Operating Cash Flow | €-1.95M | N/A |
| Capital Expenditures | €128,000 | N/A |
| Free Cash Flow | €-8.92M | N/A |
| Debt Repayment | €0 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IMCD | DSFIR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 348,546 | 656,515 |
| Average Daily Volume (90 Day) | 211,700 | 507,777 |
| Shares Outstanding | 59.07M | 259.98M |
| Float Shares | 55.45M | 247.17M |
| % Held by Insiders | 0.02% | 0.10% |
| % Held by Institutions | 0.76% | 0.30% |
Dividend Analysis & Yield Comparison: IMCD N.V vs DSM-Firmenich AG
| Metric | IMCD | DSFIR |
|---|---|---|
| Last 12-Month Dividend | €2.15 | €2.50 |
| Last 12-Month Dividend Yield | 1.91% | 2.63% |
| 3-Year Avg Annual Dividend | €2.25 | €2.20 |
| 3-Year Avg Dividend Yield | 1.71% | 2.22% |
| 3-Year Total Dividends | €6.76 | €6.60 |
| Ex-Dividend Date | Apr 29, 2025 | May 08, 2025 |